<DOC>
	<DOCNO>NCT00467129</DOCNO>
	<brief_summary>RATIONALE : Studying sample blood tumor tissue laboratory patient cancer may help doctor learn change occur DNA help doctor understand patient respond treatment . PURPOSE : This clinical trial examine gene affect disease outcome patient metastatic colorectal cancer .</brief_summary>
	<brief_title>Genes That Affect Disease Outcome Patients With Metastatic Colorectal Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Collect blood sample DNA extraction genetic study patient receive chemotherapy metastatic colorectal cancer . - Collect detailed clinical , pathological , chemotherapy data patient . - Identify genetic factor relate treatment response outcome patient . OUTLINE : Blood sample collect relevant gene region amplify PCR . PCR product sequence genotyped know biological marker single nucleotide polymorphism . Tumor sample surplus pathology specimen analyze expression candidate gene mutation candidate gene . Clinical family history data also collect questionnaire . PROJECTED ACCRUAL : A total 800 patient accrue study .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis metastatic colorectal cancer Currently receive chemotherapy Weston Park Hospital PATIENT CHARACTERISTICS : Not Specified PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>stage IV colon cancer</keyword>
	<keyword>stage IV rectal cancer</keyword>
</DOC>